Skip to main content
SpringerLink
Log in

Patient-Oriented Strategies for the Prevention of Drug Interactions

  • Leading Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Abstract

Drug interactions are a common and serious problem arising from polypharmacy. Strategies to reduce the likelihood of the co-prescription of hazardous drug combinations are likely to enhance the quality of care provided for patients requiring polypharmacotherapy. Drugs for which patient-oriented information strategies may decrease the likelihood of drug interactions tend to be those of low therapeutic index, and have interaction potential with other drugs commonly prescribed or available without prescription.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Strand LM, Morley PC, Cipolle RJ, et al. Drug-related problems: their structure and function. DICP Ann Pharmacother 1999; 24: 1093–7

    Google Scholar 

  2. Stanton LA, Peterson GM, Rumble RH, et al. Drug-related admissions to an Australian hospital. J Clin Pharm Ther 1994; 19: 341–7

    Article  PubMed  CAS  Google Scholar 

  3. Mok H, Mulpeter K, O’Connor P. Drug-drug interactions in the hospital. Ir Med J 1991; 84: 26

    PubMed  CAS  Google Scholar 

  4. Jankel CA, Fitterman LK. Epidemiology of drug-drug interactions as a cause of hospital admissions. Drug Saf 1993; 9: 51–9

    Article  PubMed  CAS  Google Scholar 

  5. Goldberg RM, Mabee J, Chan L, et al. Drug-drug and drug-disease interactions in the ED: analysis of a high-risk population. Am J Emerg Med 1996; 14: 447–50

    Article  PubMed  CAS  Google Scholar 

  6. Costa AJ. Potential drug interactions in an ambulatory geriatric population. Fam Pract 1991; 8: 234–6

    Article  PubMed  CAS  Google Scholar 

  7. Cadieux RJ. Drug interactions in the elderly. How multiple drug use increases risk exponentially. Postgrad Med 1989; 86: 179–86

    PubMed  CAS  Google Scholar 

  8. Marik PE, Fromm L. A case series of hospitalized patients with elevated digoxin levels. Am J Med 1998; 105: 110–5

    Article  PubMed  CAS  Google Scholar 

  9. Hamilton RA, Gordon T. Incidence and cost of hospital admissions secondary to drug interactions involving theophylline. Ann Pharmacother 1992; 26: 1507–11

    PubMed  CAS  Google Scholar 

  10. Jankel CA, McMillan JA, Martin BA. Effect of drug interactions on outcome of patients receiving warfarin or theophylline. Am J Hosp Pharm 1994; 51: 661–6

    PubMed  CAS  Google Scholar 

  11. Atkin PA, Stringer RS, Duffy JB, et al. The influence of information provided by patients in the accuracy of medication records. Med J Aust 1998; 169: 85–8

    PubMed  CAS  Google Scholar 

  12. Atkin PA, Finnegan TP, Ogle SJ, et al. Are medication cards useful? Med J Aust 1995; 162: 300–1

    PubMed  CAS  Google Scholar 

  13. Sansom LN, editor. Australian pharmaceutical formulary and handbook. 16th ed. Canberra, Australia: Pharmaceutical Society of Australia, 1997

    Google Scholar 

  14. Duguid MJ. CPI - education or information? Aust J Hosp Pharm 1994; 24: 229

    Google Scholar 

  15. Joseph P. Consumer product information affects us all: IV - medical practitioner view. Aust Prescr 1996; 19: 33–4

    Google Scholar 

  16. Fogg S. Consumer product information affects us all: II - consumer view. Aust Presc 1996; 19: 32

    Google Scholar 

  17. Baker SJ. Who can read consumer product information? Aust J Hosp Pharm 1997; 27: 126–31

    Google Scholar 

  18. Davidson J, Zung WW, Walker JI. Practical aspects of MAO inhibitor therapy. J Clin Psychiatry 1984; 45: 81–4

    PubMed  CAS  Google Scholar 

  19. Scalley RD, Kearney E, Jakobs E. Interdisciplinary inpatient warfarin education program. Am J Hosp Pharm 1979; 36: 219–20

    PubMed  CAS  Google Scholar 

  20. Walker JI. Use of a patient education booklet to improve compliance with lithium therapy [letter]. Psychosomatics 1981; 22: 51

    PubMed  CAS  Google Scholar 

  21. Alderman CP. Medication alert cards to minimise antidepressant drug interactions. Aust J Hosp Pharm 1998; 28: 259–60

    Google Scholar 

  22. Lacro JP, Jeste DV. Physical comorbidity and polypharmacy in older psychiatric patients. Biol Psychiatry 1994; 36: 146–52

    Article  PubMed  CAS  Google Scholar 

  23. Nemeroff CB, DeVane CL, Pollock BG. Newer antidepressants and the cytochrome p450 system. Am J Psychiatry 1996; 153: 311–20

    PubMed  CAS  Google Scholar 

  24. Adson DE, Crow SJ, Meller WH, et al. Potential drug interactions on a tertiary-care hospital consultation-liaison psychiatry service. Psychosomatics 1998; 39: 360–5

    Article  PubMed  CAS  Google Scholar 

  25. McClung HJ, Murray RD, Heitlinger LA. The internet as a source of current patient information. Pediatrics 1998; 101: E2

    Article  PubMed  CAS  Google Scholar 

  26. Dowe MC, Lawrence PA, Carlson J, et al. Patients’ use of health teaching materials at three readability levels. Appl Nurs Res 1997; 10: 86–93

    Article  PubMed  CAS  Google Scholar 

  27. Monk D. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 250–1

    Google Scholar 

  28. Tasker J, Parker S, Friedel H, et al. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 251–2

    Google Scholar 

  29. Sless D. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 252–3

    Google Scholar 

  30. Baker S. Who can read consumer product information [letter]. Aust J Hosp Pharm 1997; 27: 253–4

    Google Scholar 

  31. Lasater L, Mehler PS. The illiterate patient: screening and management. Hosp Pract 1998; 33: 169–70

    Google Scholar 

  32. Fogarty JS. Reactance theory and patient noncompliance. Soc Sci Med 1997; 45: 1277–88

    Article  PubMed  CAS  Google Scholar 

  33. Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns 1995; 26: 139–44

    Article  PubMed  CAS  Google Scholar 

  34. Chaplin R, Kent A. Informing patients about tardive dyskinesia. Controlled trial of patient education. Br J Psychiatry 1998; 172: 78–81

    Article  PubMed  CAS  Google Scholar 

  35. Arthur VA. Written patient information: a review of the literature. J Adv Nurs 1995; 21: 1081–6

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported in part by financial grants from the Medical Benefits Fund (MBF) of Australia, and the Special Purposes Trust Fund of the Repatriation General Hospital, Daw Park, South Australia.

Author information

Authors and Affiliations

  1. Departments of Pharmacy and Psychiatry, Repatriation General Hospital, Daw Park, Adelaide, South Australia, 5041, Australia

    Christopher P. Alderman

Authors
  1. Christopher P. Alderman
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christopher P. Alderman.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Alderman, C.P. Patient-Oriented Strategies for the Prevention of Drug Interactions. Drug-Safety 22, 103–109 (2000). https://doi.org/10.2165/00002018-200022020-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-200022020-00003

Keywords

Search

Navigation